Tempus | AI-enabled precision medicine
Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Next - Tempus
Learn more about Tempus Next. Chris Scotto DiVetta, SVP of Applications at Tempus AI introduces Tempus Next, an AI enabled care pathway platform that helps providers accelerate …
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, …
Jun 26, 2024 · Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug …
Investor Relations | Tempus AI
With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, …
Careers - Tempus
Tempus’ compliance with LA County’s Fair Chance Ordinance. Get to know us better. Open video in popup. Open video in popup. This is data-driven precision medicine. This is the future of …
Press Releases | News | Tempus
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s …
Job Postings & Open Positions - Tempus
Tempus is currently hiring. View open positions here. xT CDx: ... Staff Product Manager, AI & Research. Data Science - Knowledge Technologies. Chicago. remote-friendly. Senior Scientist …
Precision Oncology Solutions | Oncology Providers - Tempus
TEMPUS HUB. We offer a fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly. TEMPUS ONE. The first …
Our Team - Tempus
“I look forward to working with the Tempus team as they continue to apply technology and artificial intelligence to healthcare, deploying intelligent diagnostics that enhance research, empower …
American Medical Association Grants PLA Code to Tempus …
Jul 8, 2024 · Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that the company’s PurIST SM algorithmic test has received a …
- Some results have been removed